GRCE Financial Statements

Balance sheet, income statement, cash flow, and dividends for Acasti Pharma Inc (GRCE).


$32.19M Market Cap.

As of 06/21/2024 5:00 PM ET (MRY) • Disclaimer

GRCE Market Cap. (MRY)


GRCE Shares Outstanding (MRY)


GRCE Assets (MRY)


Total Assets

$73.30M

Total Liabilities

$11.56M

Total Investments

$0

GRCE Income (MRY)


Revenue

$0

Net Income

-$12.85M

Operating Expense

$12.85M

GRCE Cash Flow (MRY)


CF Operations

-$12.33M

CF Investing

$104.00K

CF Financing

$7.36M

GRCE Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

GRCE Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$73,300,000 (-7.36%)

$79,123,000 (-38.48%)

$128,620,000 (105.93%)

$62,458,000 (173.30%)

Assets Current

$24,010,000 (-18.03%)

$29,290,000 (-35.32%)

$45,281,000 (-27.40%)

$62,372,000 (237.84%)

Assets Non-Current

$49,290,000 (-1.09%)

$49,833,000 (-40.20%)

$83,339,000 (96805.81%)

$86,000 (-98.04%)

Goodwill & Intangible Assets

$49,266,000 (0.00%)

$49,266,000 (-40.48%)

$82,774,000 (0%)

$0 (0%)

Shareholders Equity

$61,743,000 (-9.14%)

$67,955,000 (-37.24%)

$108,270,000 (94.52%)

$55,660,000 (328.35%)

Property Plant & Equipment Net

$24,000 (-95.77%)

$567,000 (0.35%)

$565,000 (556.98%)

$86,000 (-41.50%)

Cash & Equivalents

$23,005,000 (-17.47%)

$27,875,000 (-8.12%)

$30,339,000 (-40.44%)

$50,942,000 (257.74%)

Accumulated Other Comprehensive Income

-$6,038,000 (0.00%)

-$6,038,000 (-0.02%)

-$6,037,000 (4.67%)

-$6,333,000 (19.70%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$15,000 (-99.89%)

$13,322,000 (36.09%)

$9,789,000 (0%)

Investments Current

$0 (0%)

$15,000 (-99.89%)

$13,322,000 (36.09%)

$9,789,000 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$722,000 (-9.98%)

$802,000 (46.35%)

$548,000 (3.40%)

$530,000 (-2.93%)

Trade & Non-Trade Payables

$1,684,000 (-49.52%)

$3,336,000 (5.70%)

$3,156,000 (111.39%)

$1,493,000 (-79.60%)

Accumulated Retained Earnings (Deficit)

-$211,119,000 (-6.48%)

-$198,266,000 (-27.23%)

-$155,837,000 (-6.72%)

-$146,018,000 (-15.58%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$5,514,000 (-24.95%)

$7,347,000 (-56.50%)

$16,889,000 (0%)

$0 (0%)

Total Debt

$0 (0%)

$485,000 (64.41%)

$295,000 (243.02%)

$86,000 (-41.50%)

Debt Current

$0 (0%)

$75,000 (-27.88%)

$104,000 (20.93%)

$86,000 (13.16%)

Debt Non-Current

$0 (0%)

$410,000 (114.66%)

$191,000 (0%)

$0 (0%)

Total Liabilities

$11,557,000 (3.48%)

$11,168,000 (-45.12%)

$20,350,000 (199.35%)

$6,798,000 (-31.05%)

Liabilities Current

$1,684,000 (-50.63%)

$3,411,000 (4.63%)

$3,260,000 (106.46%)

$1,579,000 (-78.65%)

Liabilities Non-Current

$9,873,000 (27.28%)

$7,757,000 (-54.61%)

$17,090,000 (227.46%)

$5,219,000 (111.81%)

GRCE Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$196,000 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$76,000 (0%)

Selling General & Administrative Expense

$6,684,000 (-19.23%)

$8,275,000 (-15.40%)

$9,781,000 (46.80%)

$6,663,000 (-21.28%)

Research & Development Expense

$4,683,000 (-53.04%)

$9,972,000 (79.38%)

$5,559,000 (33.21%)

$4,173,000 (-73.88%)

Operating Expenses

$12,852,000 (-75.36%)

$52,155,000 (234.56%)

$15,589,000 (-5.74%)

$16,539,000 (-32.32%)

Interest Expense

-$911,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

-$1,832,000 (80.80%)

-$9,542,000 (-1372.53%)

-$648,000 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$12,853,000 (69.71%)

-$42,429,000 (-332.11%)

-$9,819,000 (50.10%)

-$19,678,000 (22.87%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$12,853,000 (69.71%)

-$42,429,000 (-332.11%)

-$9,819,000 (50.10%)

-$19,678,000 (22.87%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$12,853,000 (69.71%)

-$42,429,000 (-332.11%)

-$9,819,000 (50.10%)

-$19,678,000 (22.87%)

Weighted Average Shares

$9,529,123 (28.16%)

$7,435,487 (21.09%)

$6,140,306 (148.46%)

$2,471,377 (40.25%)

Weighted Average Shares Diluted

$9,529,123 (28.16%)

$7,435,487 (21.09%)

$6,140,306 (148.46%)

$2,471,377 (40.25%)

Earning Before Interest & Taxes (EBIT)

-$15,596,000 (69.99%)

-$51,971,000 (-396.52%)

-$10,467,000 (46.81%)

-$19,678,000 (19.48%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$120,000 (0%)

Operating Income

-$12,852,000 (75.36%)

-$52,155,000 (-234.56%)

-$15,589,000 (5.06%)

-$16,419,000 (32.81%)

GRCE Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$104,000 (-99.21%)

$13,153,000 (473.45%)

-$3,522,000 (64.27%)

-$9,858,000 (-221.14%)

Net Cash Flow from Financing

$7,359,000 (2320.72%)

$304,000 (0%)

$0 (0%)

$59,490,000 (351.26%)

Net Cash Flow from Operations

-$12,333,000 (22.50%)

-$15,913,000 (7.67%)

-$17,234,000 (-20.36%)

-$14,319,000 (37.61%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$4,870,000 (-97.65%)

-$2,464,000 (88.04%)

-$20,603,000 (-156.14%)

$36,702,000 (1494.98%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$15,000 (-99.89%)

$13,170,000 (473.94%)

-$3,522,000 (64.02%)

-$9,789,000 (-215.75%)

Capital Expenditure

$89,000 (623.53%)

-$17,000 (0%)

$0 (0%)

-$69,000 (78.37%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$7,359,000 (2320.72%)

$304,000 (0%)

$0 (0%)

$59,633,000 (304.79%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

-$8,000 (-105.23%)

$153,000 (-88.98%)

$1,389,000 (238.76%)

Share Based Compensation

$913,000 (-49.59%)

$1,811,000 (35.45%)

$1,337,000 (13.88%)

$1,174,000 (-39.89%)

Depreciation Amortization & Accretion

$11,000 (-91.13%)

$124,000 (0%)

$0 (0%)

$924,000 (-60.17%)

GRCE Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

61.20%

Profit Margin

-

-

-

-10039.80%

EBITDA Margin

-

-

-

-9568.40%

Return on Average Equity (ROAE)

-20.00% (56.52%)

-46.00% (-355.45%)

-10.10% (87.00%)

-77.70% (92.60%)

Return on Average Assets (ROAA)

-17.10% (55.47%)

-38.40% (-312.90%)

-9.30% (85.02%)

-62.10% (32.57%)

Return on Sales (ROS)

-

-

-

-10039.80%

Return on Invested Capital (ROIC)

-914.30% (79.20%)

-4395.00% (-5791.42%)

-74.60% (91.91%)

-922.10% (-259.04%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.54 (-424.17%)

-0.48 (89.29%)

-4.52 (-25.21%)

-3.61 (-185.30%)

Price to Sales Ratio (P/S)

-

-

-

363.14

Price to Book Ratio (P/B)

0.52 (72.52%)

0.3 (-39.48%)

0.5 (-74.21%)

1.94 (-25.61%)

Debt to Equity Ratio (D/E)

0.19 (14.02%)

0.16 (-12.77%)

0.19 (54.10%)

0.12 (-83.93%)

Earnings Per Share (EPS)

-1.35 (76.32%)

-5.7 (-251.85%)

-1.62 (79.70%)

-7.98 (44.58%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0.08 (0%)

Free Cash Flow Per Share (FCFPS)

-1.28 (40.01%)

-2.14 (23.69%)

-2.81 (51.79%)

-5.82 (55.91%)

Book Value Per Share (BVPS)

6.48 (-29.11%)

9.14 (-48.17%)

17.63 (-21.71%)

22.52 (205.42%)

Tangible Assets Book Value Per Share (TABVPS)

2.52 (-37.19%)

4.01 (-46.22%)

7.47 (-70.46%)

25.27 (139.30%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0%)

0 (0%)

-2 (50.00%)

-4 (-300.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.88 (-968.32%)

0.1 (105.02%)

-2.01 (53.61%)

-4.33 (-511.14%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0.01 (0%)

Current Ratio

14.26 (66.04%)

8.59 (-38.18%)

13.89 (-64.84%)

39.5 (1481.94%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$12,244,000 (23.14%)

-$15,930,000 (7.57%)

-$17,234,000 (-19.78%)

-$14,388,000 (38.17%)

Enterprise Value (EV)

$13,671,959 (361.89%)

-$5,220,559 (-124.81%)

$21,040,583 (-74.11%)

$81,256,423 (417.90%)

Earnings Before Tax (EBT)

-$14,685,000 (71.74%)

-$51,971,000 (-396.52%)

-$10,467,000 (46.81%)

-$19,678,000 (22.87%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$15,585,000 (69.94%)

-$51,847,000 (-395.34%)

-$10,467,000 (44.19%)

-$18,754,000 (15.21%)

Invested Capital

-$655,000 (30.61%)

-$944,000 (-107.53%)

$12,542,000 (25.13%)

$10,023,000 (448.14%)

Working Capital

$22,326,000 (-13.73%)

$25,879,000 (-38.41%)

$42,021,000 (-30.88%)

$60,793,000 (449.32%)

Tangible Asset Value

$24,034,000 (-19.50%)

$29,857,000 (-34.88%)

$45,846,000 (-26.60%)

$62,458,000 (235.63%)

Market Capitalization

$32,192,959 (56.91%)

$20,517,441 (-62.03%)

$54,031,583 (-49.83%)

$107,697,423 (218.66%)

Average Equity

$64,294,500 (-30.35%)

$92,310,500 (-4.59%)

$96,748,250 (282.09%)

$25,321,000 (941.55%)

Average Assets

$75,182,000 (-31.93%)

$110,441,500 (4.41%)

$105,774,000 (233.84%)

$31,683,750 (14.34%)

Invested Capital Average

$1,705,750 (44.25%)

$1,182,500 (-91.57%)

$14,024,500 (557.19%)

$2,134,000 (150.63%)

Shares

9,399,404 (26.41%)

7,435,487 (0.73%)

7,381,379 (97.39%)

3,739,501 (101.55%)